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Decameric vanadate species (V10) inhibit the rate and the extent of G-actin polymerization with an IC50 of 68 ± 22 lM and
17 ± 2 lM, respectively, whilst they induce F-actin depolymerization at a lower extent. On contrary, no eﬀect on actin polymerization
and depolymerization was detected for 2 mM concentration of ‘‘metavanadate’’ solution that contains ortho and metavanadate species,
as observed by combining kinetic with 51V NMR spectroscopy studies. Although at 25 C, decameric vanadate (10 lM) is unstable in the
assay medium, and decomposes following a ﬁrst-order kinetic, in the presence of G-actin (up to 8 lM), the half-life increases 5-fold (from
5 to 27 h). However, the addition of ATP (0.2 mM) in the medium not only prevents the inhibition of G-actin polymerization by V10 but
it also decreases the half-life of decomposition of decameric vanadate species from 27 to 10 h. Decameric vanadate is also stabilized by
the sarcoplasmic reticulum vesicles, which raise the half-life time from 5 to 18 h whereas no eﬀects were observed in the presence of phos-
phatidylcholine liposomes, myosin or G-actin alone. It is proposed that the ‘‘decavanadate’’ interaction with G-actin, favored by the
G-actin polymerization, stabilizes decameric vanadate species and induces inhibition of G-actin polymerization. Decameric vanadate sta-
bilization by cytoskeletal and transmembrane proteins can account, at least in part, for decavanadate toxicity reported in the evaluation
of vanadium (V) eﬀects in biological systems.
 2006 Elsevier Inc. All rights reserved.
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Widely known for its toxic eﬀects, vanadium is vestigial
in muscle and other tissues, being considered an essential
oligoelement for humans, although its role is far from a
clear identiﬁcation [1–3]. Skeletal muscle cells and vana-
dium are strongly connected to each other, since it is
known that ATP obtained from horse skeletal muscle0162-0134/$ - see front matter  2006 Elsevier Inc. All rights reserved.
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E-mail address: maalves@ualg.pt (M. Aureliano).really contains vanadium [4,5]. Thereafter, vanadium has
a variety of physiological eﬀects acting either as a phos-
phate analogue in the monomeric form ðH2VO4 Þ or
through oligomeric vanadate species. Thus, vanadium
showed to be a powerful biochemical tool to gain a deeper
knowledge in several biochemical mechanisms such as the
regulation of muscle contraction and the modulation of
the F-actin stimulated myosin ATPase activity and its rel-
evance to actin–myosin interactions [6,7].
In vanadium (V) solutions, diﬀerent oligomeric vana-
date species can occur simultaneously in equilibrium, e.g.
monomeric (V1), dimeric (V2), tetrameric (V4) and deca-
meric (V10) and, in some cases, with diﬀerent states of
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such as vanadate concentration, pH and ionic strength
[8–10]. However, this vanadium polymorphism is not taken
into consideration in most biological studies, although it is
recognized that the individual species may have diﬀerent
eﬀects on enzyme activities [11–14]. Furthermore, the rapid
chemical equilibrium between vanadate oligomers, in the
time scale of milliseconds [15], further complicates the iden-
tiﬁcation of the vanadate species responsible for the eﬀects
promoted in biological systems. To this end a combination
of biochemical kinetic studies with 51V NMR spectroscopy
has proven to be very valuable [12,14,16], as it allows cor-
relating inhibitory eﬀects with speciﬁc vanadate species dis-
tribution in solution [12,14]. Therefore, it is of primary
importance to characterize precisely the vanadate species
and the interactions with the system before attempting to
understand the promoted eﬀects [17].
To our knowledge, it is not possible to prevent the for-
mation of decameric vanadate upon acidiﬁcation of vana-
date solutions, even at the micromolar concentration
range. In fact, many researchers working in diﬀerent areas
ranging from life sciences to chemical engineering, using
vanadate in their studies, frequently observed the orange/
yellow color in their solutions. This is due to the occurrence
of decameric vanadate; for instance in a cell culture, after
an acidiﬁcation procedure during protein puriﬁcation, after
the adjustment of the pH value of the reaction medium or
even in methods for vanadate quantiﬁcation. Once formed,
decameric vanadate decomposition is in general slow
enough, to allow the study of its eﬀects even in the micro-
molar range [7,18]. However, it may become inaccessible to
deoligomerization due to their stabilization upon binding
to target macromolecular structures [19]. Recent work
from our laboratory [20–23] demonstrated that an acute
exposure to decameric vanadate species, but not exposure
to monomeric vanadate, induces changes on vanadium
accumulation and in overall stress markers. Altogether,
these observations reveal that decameric vanadate plays
an important role in the evaluation of vanadium (V) toxic-
ity in biological systems [17].
Monomeric actin, G-actin, polymerizes to F-actin, the
major component of cytoskeletal microﬁlaments in non-
muscle cells and of thin ﬁlaments in muscle cells. For all
eukaryotic cells alterations of the G-actin/F-actin equilib-
rium will aﬀect a wide variety of biological processes of
high relevance for cell life such as locomotion, cytokinesis,
phagocytosis and the acrossomal process of sperm [24].
It has been described that vanadate stabilizes F-actin ﬁl-
aments through the formation of F-actin-ADP.Vi com-
plexes [24] and it induces actin polymerization by
inhibiting speciﬁc tyrosine phosphatases [25]. It was
recently reported some vanadate eﬀects on actin polymeri-
zation including sperm capacitation, detachment of patho-
genic microorganisms and chemotherapy of solid tumors
[25–27]. In plant cells it has been described that vanadate
(up to 4 mM) inhibits cell elongation due to the disruption
of actin microﬁlaments [28]. At neutral pH and through themillimolar range of vanadate concentrations most fre-
quently employed in those biochemical studies, the pre-
dominant vanadate species are not only the monomeric
ðH2VO4 Þ, but also others vanadate oligomers such as
dimeric ðH3V2O7 Þ and cyclic tetrameric forms ðV4O412 Þ
[8]. Besides, upon medium acidiﬁcation, decameric vana-
date species may also occur. Therefore, the putative eﬀects
of the diﬀerent vanadate oligomers in actin structure and
function are still to be clariﬁed and to our knowledge have
not been done yet. Using actin from rabbit skeletal muscle
we report the eﬀects of a decavanadate solution on the
capacity of actin to polymerize. Our results suggest that
decameric vanadate interactions with actin inhibit G-actin
polymerization and stabilize decameric vanadate species.
2. Materials and methods
2.1. Vanadate solutions
Metavanadate solution (50 mM, pH 6.0–7.0) was pre-
pared from ammonium metavanadate (NH4VO3) pur-
chased from Riedel-de-Haen. Decavanadate solution was
prepared in a manner that maximized the proportion of
vanadate present as the decamer, by adjusting the pH
of the metavanadate solution to 4.0 [29]. The presence of
decameric vanadate species was revealed by a characteristic
orange color. Both solutions were kept at 4 C. Decavana-
date solutions were always ascertained to pH 6.0, immedi-
ately before using. Wherever adjustable, decavanadate
solutions were added to the assays from the concentrated
or from a 10-fold dilution of the stock solutions.
2.2. Proteins and vesicles preparations
Actin was extracted from acetone powder of rabbit skel-
etal muscle in buﬀer G [Tris 2 mM, pH 8.0, ATP 0.2 mM,
CaCl2 0.2 mM, b-mercaptoethanol 0.5 mM, NaN3 0.005%]
as described by Pardee and Spudich [30]. G-actin (Mr
42,300) concentration was determined by measuring absor-
bance at 290 nm using an extinction coeﬃcient of
0.617 mg1 mL cm1 [31]. Myosin was prepared from leg
and dorsal rabbit skeletal muscle, as previously described
by Pires et al. [32]. Myosin subfragment-1 (S1), was pre-
pared as indicated in Tiago et al. [7]. S1 (Mr 115,000) con-
centration was determined spectrophotometrically by using
an extinction coeﬃcient of e1%280 ¼ 7:5 cm1.
Sarcoplasmic reticulum vesicles (SRV) were prepared
from white skeletal rabbit muscle as described elsewhere
[29]. Isolated SRV suspended in KCl 0.1 M, Tris 10 mM,
pH 7.0, were diluted 1:1 with sucrose 2 M and frozen
in liquid nitrogen prior to storage at 80 C. Protein con-
centration was determined by the biuret method, using
bovine serum albumin as a standard [33]. The percentage
of each protein present in the SRV preparations was
determined through densitometry analysis of sodium
dodecyl sulphate (SDS)–polyacrylamide gel electrophoresis
(7.5% acrylamide). The SR Ca2+-ATPase analyzed by
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of the total protein in SRV.
Liposomes were prepared according to a modiﬁed
protocol from the standard method revised by Szoka and
Papahadjopoulos [34]. POPC (1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine) was obtained from Avanti
Polar-Lipids (purity >99.9%) and a 5 mM stock solution
in a chloroform:methanol (2:1) solvent was prepared,
0.5 ml of the stock solution were dried using a rotary evap-
orator Heidolph VV-micro and a vacuum pump Bu¨chi V-
500 (with a V-800 vacuum control) during approximately
1 h. The resulting lipid ﬁlm on the ﬂask walls was hydrated
at 30 C (well above the main phase transition temperature
of POPC, 2 C) for about 1 h and vortexed regularly to
produce a suspension with multilamellar vesicles. An aque-
ous buﬀer of Tris 2 mM, pH 7.5, was used for hydration
with a volume of 5 ml added to the ﬂask to obtain a ﬁnal
POPC concentration of 0.5 mM.
2.3. Kinetic studies
The kinetics of dissociation of decameric species was
determined from measurements of the absorption at
400 nm (an absorption band which is characteristic of deca-
meric vanadate), using a Shimadzu UV-2401PC spectropho-
tometer with 100 lM total vanadate concentration, i.e.
10 lMdecameric vanadate species, in the several experimen-
tal medium conditions used in this study. Proteins or lipo-
somes, wherever indicated, were added (1, 2, 4 and 8 lM)
just before starting the measurements. Several reaction
media were used: G-actin : (2 mM Tris, 0.2 mM CaCl2,
10 lM ATP, 100 mM KCl, 2 mM MgCl2, pH 7.5; 2 mM
Tris, 0.2 mM CaCl2, 0.2 mM ATP, 100 mM KCl,
2 mM MgCl2, pH 7.5; and 2 mM Tris, 0.2 mM CaCl2,
0.2 mM ATP, pH 7.5) and F-actin (2 mM Tris, 0.2 mM
CaCl2, 10 lM ATP, 100 mM KCl, 2 mM MgCl2, pH 7.5);
myosin S1 (2 mM Tris, 0.2 mM CaCl2, 0.2 mM ATP, pH
7.5); liposomes (2 mM Tris, pH 7.5); sarcoplasmic vesicles
(0.1 M KCl, 5 mM MgCl2, 25 mM HEPES, pH 7.0,
50 lM CaCl2 and 500 lMATP). The reactions were started
after addition of 100 lMdecavanadate (10 lMof decameric
vanadate specie) to the medium containing the samples (1, 2,
4 and 8 lM) and the kinetics were followed during 60 min.
2.4. Light-scattering measurements
F-actin depolymerization and G-actin polymerization
were monitored, using a Jobin Yvon-Horiba FluoroMax-
3 spectroﬂuorimeter, at 25 C, by the light scattering inten-
sity change at 90 with respect to the incident light, with
both monochromators set at 546 nm [35], slits of 1.0 nm
and adequate time acquisition setup. The reaction was
started by the addition of the polymerization solution
(100 mM KCl, 2 mM MgCl2) to 8 lM of G-actin in 2 mM
Tris, 0.2 mM CaCl2, 10 lM ATP (pH 7.5) in the absence
or in the presence of the meta or decavanadate solutions
(1, 2, 4 and 8 mM). The reactions were followed during 1 h.2.5. NMR measurements
51V NMR spectroscopy measurements were performed
on a Bruker AM-400 MHz spectrometer at 105.2 MHz
equipped with a 5 mm multinuclear inverse probe. Spectra
were acquired at 22 C, using 0.5 ml of samples containing
10% D2O, under the following conditions: 90 pulse angle,
spectral width 45,454 Hz, acquisition time 0.086 s, number
of transients between 12,000 and 25,000 and relaxation
delay 0.01 s. For quantitative measurements all the spectral
parameters were kept constant [29].
51V NMR chemical shifts are reported relative to an
external reference of VOCl3 (0 ppm). NMR spectra of
metavanadate (1, 2, 4 and 8 mM) and decavanadate (1, 2,
4 and 8 mM) solutions were obtained in a reaction medium
for G-actin polymerization containing 2 mM Tris, 0.2 mM
CaCl2, 100 mM KCl, 2 mM MgCl2, pH 7.5 in the absence
and presence of 20 lM G-actin, 20 lM F-actin or ATP
(1 mM) as desired. The 51V NMR line widths of the several
free and bound vanadate resonances represent the widths
at half-height after subtraction of 20 Hz used in line broad-
ening. The concentrations of each vanadate species Vx were
calculated from the fractions of the total integrated areas
using the following equation: [Vx] = (Ax/At) · ([Vt]/n),
where Ax corresponds to the area measured for the x van-
adate species with n as the oligomer number (number of
vanadium atoms), At the sum of measured areas, and [Vt]
the total vanadate concentration, according to described
elsewhere [29].
3. Results and discussion
3.1. Decavanadate inhibition of G-actin polymerization
Recently, it was described that decameric vanadate
binds with high aﬃnity near the back door of the catalytic
site of myosin subfragment 1, producing non-competitive
inhibition of the F-actin stimulated S1 ATPase activity,
without signiﬁcant dissociation of the acto-S1 complex
[7]. The possibility that the inhibition of the F-actin stimu-
lated myosin ATPase activity could be due to decavanadate
interactions with F-actin, instead with myosin, was
excluded since the decameric vanadate concentrations used
(up to 200 lM total vanadate, i.e. nearly 20 lM of deca-
meric vanadate species) had no eﬀect on the rate of G-actin
polymerization or F-actin depolymerization. In this paper
we have considered the possibility that at higher concentra-
tions decameric vanadate can also interact with G-actin
and F-actin.
Upon addition of decavanadate, it was veriﬁed an inhi-
bition of the G-actin polymerization (Fig. 1). We mean by
‘‘decavanadate’’ a solution containing besides decameric
vanadate species also monomeric vanadate species, as
described in the following section. For decavanadate, the
best curve that ﬁts to experimental data point is an expo-
nential decay for a second-order process, with IC50 inhibi-
tion values for G-actin polymerization of 0.17 and 3.7 mM
Fig. 1. Time course of G-actin (8 lM) polymerization (in Tris 2 mM,
CaCl2 0.2 mM, ATP 10 lM, pH 7.5), monitored by light-scattering at
546 nm, 25 C, in the absence (a) and in the presence of 4 mM (b) and
8 mM (c) of decavanadate (total vanadate concentration) added to the
buﬀer just before starting the polymerization (with KCl 100 mM, MgCl2
2 mM) at 25 C.
Fig. 2. G-actin (8 lM) polymerization (in Tris 2 mM, CaCl2 0.2 mM,
ATP 10 lM, pH 7.5) was induced by 100 mM KCl, 2 mM MgCl2. (a)
Extent of G-actin polymerization upon addition of various concentrations
(total vanadate) of decavanadate (j) and metavanadate (m) relative to G-
actin (control). (b) Rate of G-actin polymerization in the presence of a
range of concentrations (total vanadate) of decavanadate.
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decameric vanadate species (V10) (Fig. 2a and b). The
extent of G-actin polymerization was inhibited by deca-
meric vanadate with an IC50 of 68 ± 2 lM (ﬁrst-order pro-
cess), whilst it induces F-actin depolymerization at a lower
extent (data not shown). Conversely, no eﬀect on actin
polymerization and depolymerization was detected for
2 mM concentration of ‘‘metavanadate’’ solution that con-
tains V1, V2 and V4 vanadate species (Fig. 2a). Besides
V10, tetrameric vanadate species may also contribute to
the inhibition of actin polymerization as observed by com-
bining kinetic with 51V NMR spectroscopy studies. In fact,
increasing metavanadate concentration (from 2 to 8 mM),
favors the formation of tetrameric vanadate species, as
observed by NMR spectroscopy (Figs. 3 and 4). This van-
adate solution inhibits G-actin polymerization, reaching
50% inhibition with 4 mM total vanadium (Fig. 2). When
ATP (1 mM) was added to the reaction medium the inhib-
itory eﬀects described above for decavanadate and meta-
vanadate solutions were blocked.
During the actin polymerization process, ATP bound to
G-actin is hydrolyzed to ADP that remains bound to F-
actin. By inhibiting G-actin polymerization, decameric
vanadate may prevent microﬁlaments formation and F-
actin stimulation of myosin ATPase activity. The release
of Pi induces depolymerization of F-actin whereas bound
ADP.Pi stabilizes the ﬁlament [24]. On the other hand, for-
mation of the ADP.Vi complex will produce stabilization
of F-actin as previously suggested [24]. Taking into account
these observations, and since the addition of ATP to the
medium prevents the inhibitory eﬀect of decameric vana-
date on G-actin polymerization, it is suggested that deca-
meric vanadate may inhibit G-actin polymerization
through a mechanism involving the ATP binding site, a siteclose to it or to a site that is exchange after subtract bind-
ing. By inhibiting G-actin polymerization, decameric vana-
date eventually prevents microﬁlaments formation and
F-actin stimulation of myosin ATPase activity. However,
before attempting to understand the eﬀects promoted by
each individual vanadate species that may occur in the
reaction medium, it is of primary importance to character-
ize precisely the vanadate solutions and the interactions
with the system by using 51V NMR spectroscopy [17].
3.2. NMR characterization of metavanadate and
decavanadate solutions
Although it is possible to obtain exclusively one vana-
date species in a decavanadate stock solution, millimolar
concentrations of metavanadate solutions contain ortho
and metameric vanadate species as observed by NMR
Fig. 3. 105.2 MHz 51V NMR spectra, at 22 C, of diﬀerent concentrations (total vanadate), namely 1, 2, 4 and 8 mM of metavanadate in a medium
containing 2 mM Tris, 0.2 mM CaCl2, 100 mM KCl, 2 mM MgCl2, pH 7.5. V1 and V2 NMR signals correspond, respectively, to monomeric ðH2VO4 Þ
and dimeric ðHV2O37 and H2V2O27 Þ vanadate species irrespective of the protonation state, whereas V4 and V5 correspond to cyclic tetrameric ðV4O412 Þ
and pentameric ðV5O515 Þ vanadate species.
Fig. 4. Vanadium (V) species composition of the metavanadate solutions
used in the assays. A series of 51V NMR spectra of the metavanadate
solutions were recorded at concentrations up to 8 mM, in a medium
containing 2 mM Tris, 0.2 mM CaCl2, 100 mM KCl, 2 mM MgCl2, pH
7.5, at 22 C. The concentrations of each vanadium (V) species were
calculated from the fractions of the total integrated areas observed in the
spectra.
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tions at the micromolar range, orthovanadate species are
exclusively present [14]. 51V NMR spectra of nominal
4 mM metavanadate solution that inhibits G-actin poly-
merization by 50%, contains 740 lM monomeric (V1),
185 lM dimeric (V2), 639 lM tetrameric (V4) and 67 lM
pentameric (V5) species (Fig. 4). A signiﬁcant increase of
V4 concentration is observed for higher concentrations of
vanadate study (4 and 8 mM) (Fig. 4).
Conversely to metavanadate solutions, which have sev-
eral vanadate species in rapid equilibrium, decavanadate
solutions (2–8 mM) contain decameric vanadate species
and monomeric vanadate species (Fig. 5). 51V NMR spec-
tra of decavanadate solutions (from 2 to 8 mM total vana-
dium) display signals from decameric vanadate species:
V10A at 515 ppm, V10B at 500 ppm and V10C at
424 ppm and also a signal ascribed to monomeric species
at 560 ppm. In the decavanadate solutions, the concen-
tration of decameric vanadate increases linearly with total
vanadate concentration, whereas monomeric vanadate
remains approximately constant (Fig. 6). Therefore, when
the stock solution of decavanadate is diluted, for instance,
into the reaction medium at low concentrations (2 mM
Fig. 5. 105.2 MHz 51V NMR spectra, at 22 C, of diﬀerent concentrations (total vanadate), namely 1, 2, 4 and 8 mM of decavanadate in a medium
containing 2 mM Tris, 0.2 mM CaCl2, 100 mMKCl, 2 mMMgCl2, pH 7.5. V1 NMR signal corresponds to monomeric ð H2VO4 Þ, while V10A, V10B and
V10C signals correspond, respectively, to the V(2), V(1) and V(3) vanadium atoms in the decameric vanadate specie ðV10O628 Þ.
S. Ramos et al. / Journal of Inorganic Biochemistry 100 (2006) 1734–1743 1739total vanadium equivalent to about 200 lM decameric spe-
cies), 51V NMR spectra shows an additional signal from
monomeric vanadate, that is, decameric vanadate is partial
disintegrated or decomposed into monomeric vanadate
species. This observation means that the solution contains
besides decameric vanadate (180 lM) also monomeric van-
adate (200 lM), that is, about 1:1 stoichiometry of deca-
meric and monomeric vanadate species. However, upon
increasing decavanadate concentration (from 2 to 8 mM)
monomeric vanadate concentration remained approxi-
mately constant (Fig. 6).Fig. 6. Vanadium (V) species composition of the decavanadate solutions
used in the assays. A series of 51V NMR spectra of the metavanadate
solutions were recorded at concentrations up to 8 mM, in a medium
containing 2 mM Tris, 0.2 mM CaCl2, 100 mM KCl, 2 mM MgCl2, pH
7.5, at 22 C. The concentrations of each vanadium (V) species were
calculated from the fractions of the total integrated areas observed in the
spectra.3.3. UV/Vis characterization of decavanadate solutions
In contrast to the labile oxovanadates, which intercon-
vert on the time scale of milliseconds to seconds, decameric
vanadate has very slow decomposition kinetics upon dilu-
tion. The kinetics of dissociation of decameric species, at
25 C, in the reaction medium used for G-actin polymeriza-
tion, assessed by measurements of the absorption at
400 nm conﬁrms a ﬁrst-order kinetic process, with an
half-time of 5 h (measured with 100 lM total vanadate
concentration, i.e. 10 lM decameric vanadate species).
Fig. 8. Second derivative of UV/Vis absorption values (arbitrary units) at
358 and at 400 nm, as a function of decavanadate concentration (total
vanadate).
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during the period used in the light-scattering experiments
(1 h).
Although NMR spectroscopy is an essential technique
for the analysis of vanadate oligomers composition, about
1 h of acquisition time is needed to obtain a spectrum of a
1 mM decavanadate solution; thus, NMR cannot do the
kinetic of the decomposition of decameric species. How-
ever, the disappearance of decameric vanadate species
can be easily followed by UV/Vis spectroscopy. UV/Vis
spectra of several decavanadate solutions were obtained
immediately after dilution (from 0.025 to 1 mM total
vanadate) and in the experimental medium used in the
polymerization studies. An extinction coeﬃcient of
e400 = 645 M
1 cm1 was obtained for the decameric vana-
date oligomer. The decameric species can be also evaluated
by second derivative of the UV/Vis spectra of ‘‘decavana-
date’’ solutions (Fig. 7). As observed in Fig. 7, ‘‘decavana-
date’’ concentration is proportional to the increase of the
2nd derivative bands at 358 and 400 nm ascribed to deca-
meric species. A linear correlation is obtained from 10 to
100 lM of decameric vanadate, i.e. from 100 to 1 mM total
vanadate concentration (Fig. 8). Therefore, in the experi-
mental conditions used in this study, total decameric vana-
date concentrations as low as 10 lM can be detected by
UV/Vis spectroscopy.
3.4. Stabilization of decameric vanadate by G-actin under
polymerization
It was observed that at 25 C, the half-life time of deca-
meric vanadate (10 lM) increases up to 5-fold, from 5 to
27 h, in the presence of increasing concentrations of G-
actin in the medium used to induce G-actin polymerization,
and for a stoichiometric concentration of ATP (Fig. 9,
black square). The increase of the half-life of decameric
vanadate upon increasing the protein concentration canFig. 7. Second derivative of UV/Vis absorption spectrum of decavanadate
(in 2 mM Tris, 0.2 mM CaCl2, 100 mM KCl, 2 mM MgCl2, pH 7.5) at
25 C. Decavanadate concentrations (total vanadate): (a) 0.025 mM; (b)
0.05 mM; (c) 0.1 mM; (d) 0.25 mM; (e) 0.5 mM; (f) 0.75 mM; (g) 1.0 mM.be rationalized in terms of a complex formation between
decameric vanadate and G-actin. Considering two equilib-
rium reactions, one between V10 and V1 and the other
between V10 and the protein, and taking into account that
the ﬁrst one is much slower (time scale of hours) than the
second (time scale of seconds or minutes at most) we can
deduce that the velocity of decomposition of decameric
vanadate species is inversely proportional to the increase
of the protein concentration [37–39].Fig. 9. Decavanadate (100 lM total vanadate, 10 lM decameric vanadate
species) half-life time in presence of: (j) G-actin (in 2 mM Tris, 0.2 mM
CaCl2, 10 lM ATP, 100 mM KCl, 2 mM MgCl2, pH 7.5); (d) G-actin (in
2 mM Tris, 0.2 mM CaCl2, 0.2 mM ATP, 100 mM KCl, 2 mMMgCl2, pH
7.5); ( ) G-actin (in 2 mM Tris, 0.2 mM CaCl2, 0.2 mM ATP, pH 7.5);
(m) F-actin (in 2 mM Tris, 0.2 mM CaCl2, 10 lM ATP, 100 mM KCl,
2 mM MgCl2, pH 7.5); (.) S1 (in 2 mM Tris, 0.2 mM CaCl2, 0.2 mM
ATP, pH 7.5); (r) SRV (in 0.1 M KCl, 5 mM MgCl2, 25 mM HEPES,
50 lMCaCl2, 500 lMATP, pH 7.0); (w) Liposomes (POPC multilamellar
vesicles in 2 mM Tris, pH 7.5).
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actin concentration between 4 and 8 lM, and for 10 lM of
decameric vanadate species, thus suggesting that the G-
actin:V10 stoichiometry is approximately one or higher,
contrarily to sarcoplasmic reticulum calcium ATPase with
about ﬁve decameric vanadate molecules per calcium pump
(Fig. 9, black lozenge).
The addition of ATP (200 lM) to the medium prevents
the inhibition of G-actin polymerization by V10 and also
decreased the half-life time of decameric vanadate species,
from 27 to 10 h (compare black square with black circle). A
similar pattern was also obtained for the decameric half-life
time upon increasing F-actin concentration or G-actin in
the presence of ATP (Fig. 9, compare black up triangle
and black circle), suggesting that both the forms of actin,
F-actin ﬁlaments or the G-actin.ATP, may behave as a sim-
ilar target for decameric vanadate species. On the other
hand, no changes on decameric vanadate half-life were
observed upon G-actin (8 lM) addition in an experimental
medium that does not induced polymerization (black hexa-
gon), pointing out that V10 does not bind to the ATP bind-
ing site by itself. Taking into consideration that the highest
half-life value for decameric (10 lM) decomposition was
observed when G-actin is under polymerization conditions
(Fig. 9, black square), it implies that decameric vanadate
stabilization may be favored by the occurrence of G-actin
polymerization for equimolar ATP concentrations. Fur-
thermore, decameric vanadate stabilization may be favored
by the occurrence of G-actin polymerization/depolymeriza-
tion equilibrium. These results suggest two possibilities for
decameric vanadate interaction with G-actin: (i) through
binding to G-actin-ATP complex at binding site close to
ATP binding site or (ii) at another binding site. As in F-
actin ﬁlament the ATP binding site is not accessible, it is
most likely that V10 binds to a diﬀerent binding site from
ATP. It is suggested two possibilities of decameric vana-
date interaction with G-actin: through binding to G-
actin-ADP.Pi complex at binding site close to ATP binding
site or to a site that is exchanged after subtract binding.
However, studies are currently in course in order to clearly
understand the interaction of decameric vanadate species
with actin.
It is recognized that decavanadate interacts with many
enzymes. To gain a better understanding of the above
observations we have studied the eﬀects of other proteins
in the stability of decameric vanadate, in particular those
known to be inhibited by decavanadate and related with
the regulation of muscle contraction, namely the contrac-
tile protein myosin and the transmembrane protein Ca2+-
ATPase which plays a major role in the decrease of
cytosolic calcium leading to muscle relaxation. It was also
observed that decameric vanadate is also stabilized by the
calcium pump from sarcoplasmic reticulum whereas no
eﬀects were observed in the presence of liposomes or
myosin subfragment-1 (Fig. 9). The absence of eﬀect upon
addition of liposomes indicates that stabilization with SRV
is due to the membrane-bound proteins, not by the lipidbilayers. It is to be noted that in the sarcoplasmic reticulum
vesicles (SRV), besides the calcium pump, other proteins
may contribute for decameric vanadate stabilization since
the vesicles contain also signiﬁcant amounts of calsesque-
strin (10%) and glycogen phosphorylase (16%), as observed
by SDS–PAGE (results not shown).
3.5. 51V NMR analysis of the interaction of G-actin with
decavanadate
As it was described above, the rate of decomposition of
decameric vanadate is much slower in the presence of G-
actin than in the presence of F-actin. In order to under-
stand the interactions of the diﬀerent forms of actin with
V10 we carried out NMR experiments indicated below.
Upon addition of G-actin (20 lM) to 2 mM of decavana-
date, in the presence of 10 lM ATP, the 51V NMR signal
at 515 ppm broadens (from 167 to 205 Hz) and its inten-
sity decreases (Fig. 10a and b). The presence of higher con-
centrations of ATP in the medium (0.2 mM) did not
signiﬁcantly change the NMR spectra upon addition of
G-actin being the V10 signals very similar in both condi-
tions point out that by increasing the concentration of
the protein natural ligand it does not prevent or favored
V10 interaction (Fig. 10c). However, the addition of F-
actin to decavanadate solutions (Fig. 10d) produced a
stronger broadening (from 167 to 318 Hz (1.9-fold) in the
V10A signal from the decameric vanadate species, whereas
the decrease in the intensities of the decameric vanadate
resonances is more pronounced in comparison with the
addition of G-actin (Fig. 10b). The results observed for
F-actin are in good agreement with the 1.5-fold broadening
of V10 NMR signal in the presence of 20 lM of F-actin
[40]. Apparently, G-actin does not broaden decameric van-
adate signals unless there is enough time to induce the for-
mation of F-actin (Fig. 10e). In this experimental
condition, the NMR spectra were obtained 90 min after
G-actin addition in the medium that induces its polymeri-
zation into F-actin. The V10 signals became broadened
and the intensity decreases in a similar pattern observed
for F-actin, although to a lower extent, whereas a pro-
nounced increase (3-fold) of monomeric vanadate species
is observed (Fig. 10e).
It is to be noted that if it occurs total disintegration or
decomposition of decameric vanadate species, for 2 mM
decavanadate concentration, besides monomeric vanadate
species, V1, others vanadate oligomers may appear in solu-
tion such as divanadate (V2) and tetravanadate (V4), as
observed by NMR, while the color of the vanadate solution
changes from pale yellow to colorless (not shown). How-
ever, this process, as it was described above, is very slow
not allowing observing the total decomposition of deca-
vanadate in the presence of the proteins since they denature
for such a long incubation time.
Our results do not allow to clearly deﬁne the eﬀects pro-
moted by each individual vanadate species that occur
simultaneously in solution, or to completely deﬁne the
Fig. 10. 105.2 MHz 51V NMR spectra, at 22 C, of decavanadate 2 mM (total vanadate) in (a) 2 mM Tris, 0.2 mM CaCl2, 100 mMKCl, 2 mMMgCl2, pH
7.5 and with: (b) 20 lMG-actin plus 10 lM ATP, (c) 20 lM G-actin plus 0.2 mM ATP, (d) 20 lM F-actin plus 10 lM ATP, and (e) solution b measured
after 90 min. V1 NMR signal corresponds to monomeric ðH2VO4 Þ, while V10A, V10B and V10C signals correspond, respectively, to the V(2), V(1) and
V(3) vanadium atoms in the decameric vanadate specie ðV10O628 Þ.
1742 S. Ramos et al. / Journal of Inorganic Biochemistry 100 (2006) 1734–1743interactions of decavanadate with actin. It was clear,
however, that decameric vanadate inhibits G-actin
polymerization.
In conclusion, it is suggested that ‘‘decavanadate’’ inter-
action with G-actin is favored during G-actin polymeriza-
tion, stabilizes decameric vanadate species and induces
inhibition of G-actin polymerization. Decameric vanadate
modulates the actin polymerization/depolymerization equi-
librium which is diﬀerent to the one described for mono-
meric vanadate. It is proposed that decameric vanadate
stabilization by cytoskeleton and membrane-bound pro-
teins can account, at least in part, for decavanadate toxicity
in biological systems.4. Abbreviations
ATP adenosine 5 0-triphosphate
ADP adenosine 5 0-diphosphate
F-actin polymerized form of monomeric actin
G-actin actin monomeric form
Hepes 4-(2-hydroxyethyl)-1-piperazine ethane
sulfonic acid
M myosin
Pi inorganic phosphate
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
S1 myosin subfragment 1
SDS sodium dodecyl sulfateTris tris(hydroxymethyl)aminomethane
SRV sarcoplasmic reticulum vesicles
UV/Vis ultraviolet/visible
V1 orthovanadate or monomeric vanadate species
V10 decameric vanadate species
V2 dimeric vanadate species
V4 tetrameric vanadate specie
V5 pentameric vanadate speciesAcknowledgments
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